Constipation Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

During the forecast period of 2017 to 2025, the global market for constipation treatment is expected to grow at a strong CAGR of 7.1 percent. The growth of the constipation treatment market is mostly due to the world's growing geriatric population, since persons over the age of 50 are more prone to irregular bowel movements. Other factors encouraging the worldwide constipation treatment market include consistent research & development to develop novel, more efficient medications, improved healthcare infrastructure in various emerging nations, and growing awareness among end-users.

On the other hand, patients' ongoing reliance on over-the-counter medications, as well as large unmet demands in rural parts of emerging countries, are impeding the worldwide constipation treatment market's optimal flourishing. The global constipation treatment market, which was valued at US$12.58 billion in 2016, is expected to grow to US$22.93 billion by the end of the forecast period, in 2025.

The global market for constipation therapy is divided into laxatives, peripherally acting mu opioid receptor antagonists, chloride channel activators, GC-C agonists, and 5-HT4 receptor agonists based on therapeutic choice. The laxatives section, which is divided into bulk forming agents, stimulant laxatives, and osmotic laxatives, had the highest demand share in 2016.

The laxatives sector is expected to be the most promising and dominate the market share over the forecast period. The success of this laxatives segment is due to two important factors: affordability for the public due to low prices and extensive availability. From 2017 to 2025, the GC-C agonists sector is expected to grow at the fastest rate of 8.7%.

The global constipation treatment market is divided into three categories based on the type of disease: irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation. During the projection period of 2017 to 2025, the opioid induced constipation sector is expected to grow at a CAGR of 7.5 percent. Hospital pharmacies, retail pharmacies, and online pharmacies are the three types of pharmacies in the global market. In the near future, the retail pharmacies segment is expected to hold a significant proportion of the worldwide constipation treatment market.